SEX CELLS! On the importance of sex and gender in brain health
Last week, we welcomed neuroscientists Liisa Galea (Centre for Addiction and Mental Health) and Robert-Paul Juster (Université de Montréal) for SEX CELLS!, a vital conversation on implementing Sex- and Gender-Based Analysis Plus (SGBA+) in health research.
HBHL gets solid representation at 2025 Bravo Gala
The 2025 Bravo Gala was a celebration of McGill University's research community, and HBHL is proud to have been so well represented. Congratulations to the following HBHL-supported researchers for these outstanding awards:
March Neurogenesis talks explore brain mechanisms in food choice and computational modelling
Last week, HBHL hosted the third talk of the 2024-2025 Neurogenesis Speaker Series at the Neuro, featuring Dana Small and Yashar Zeighami.
AI analysis of healthcare records reveals key factors in autism diagnosis
Scientists argue the criteria we use for diagnosing autism may need revisionWithout clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro
Free, online training program strengthens training and brings specialized care to communities across QuebecA healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub.
Latest Alzheimer’s drug shown less effective in females than males
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.
Genetic sequencing project receives more than $8 million in funding
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians
A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of McGill University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.
Project to create AI model for ALS receives Génome Québec funding
$400,000 will fuel public-private collaboration to discover new disease biomarkers
Achievements of clinicians and scientists recognized with King Charles III Coronation Medals
Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.
Mentorship Lunch: What's the next step?
What if career steering and planning did not have to wait until graduation?
Prescribing anti-swelling drug reduces immune response weeks after last dose
Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy
Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.
Six principal investigators from The Neuro receive CIHR grants
Projects include important research on Parkinson’s, glioblastoma and dementia
First Neurogenesis talk of 2025 highlights learning and spatial coding
Yesterday, HBHL hosted the first Neurogenesis Speaker Series talk of 2025 at The Neuro, featuring Paul Masset and Pouya Bashivan.
HBHL-funded researchers clinch CIHR Fall 2024 Project Grant
The Canadian Institutes of Health Research's Project Grant: Fall 2024 competition has approved 453 research grants for a total investment of approximately $411M, with 131 projects funded in Quebec.
HBHL is proud to announce that 16 HBHL-funded researchers will receive support for eight projects, out of 23 grants awarded at McGill.
An open solution to improving research reproducibility
Academic and industry scientists collaborate on a new method to characterize research antibodiesStructural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McGill University, in collaboration with scientists from 11 major antibody manufacturers representing approximately 80 per cent of global renewable antibody production, have developed and standardized an Open Science platform to characterize research antibodies.